SLIDES
1. Respiri
2. Respiri is Launch Ready
3. Respiri set to achieve $6M-$8M Sales in CY 2021
4. MODELS & BUSINESS CHANNELS
5. LARGE MARKET WITH UNMET NEEDS AWAITS WHEEZO
6. WHEEZO - PROVIDING CARE BEYOND THE CLINIC
7. WHEEZO - PROVIDING CARE BEYOND THE CLINIC
8. INDICATIVE TIMELINE OF MILESTONES & ACHIEVEMENTS
9. PATHWAY TO COMMERCIALISATION
10. PARTNERSHIPS
11. WHEEZO EXPERIENTIAL PROGRAM
12. LATEST ALGORITHM DEVELOPMENT
13. LATEST ALGORITHM DEVELOPMENT. A POTENTIAL NEW STANDARD.
14. Respiri set to achieve $6M-$8M Sales in CY 2021
15. Thank you
16. Forward Looking Statements
17. Respiri Limited (The Company) Risk Factors
Respiri (ASX.RSH).pdf
1 / 17